Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.

Slides:



Advertisements
Similar presentations
Why does ERA Need to Flourish
Advertisements

Mutual accountability and aid transparency Mutual accountability and aid transparency Republic of Moldova 1IATI meeting, OECD Conference center.
1 ESA/STAT/AC.219/8 Region-wide Programme to Improve Vital Statistics and Civil Registration Systems prepared by: Margarita F Guerrero, Ph D Regional Adviser.
TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
Jean-Michel Courades, DG AGRI Rural Development Networking and Cooperation
European Commission Justice Date | # EQUS Conference, June 2011 Building an EU Consensus for minimum quality standards in drug demand reduction -
The Implementation Structure DG AGRI, October 2005
The EMCDDA and the Reitox network: towards quality achievement Sandrine Sleiman, Scientific Committee, Palmela, February 2008.
Operational Programme I – Cohesion Policy Event part-financed by the European Union European Regional Development Fund Evaluation Plan for Maltas.
G L O B A L E N V I R O N M E N TAL I N F O R M A T I O N N E T W O R K Ecoinformatics and UNEP Ecoinformatics – Role in Global Informatics, Assessments.
Building an EU consensus for minimum quality standards June 2011, Brussels | WHO: Normative guidance on and quality standards in drug demand reduction.
Together. Free your energies How open and collaborative are public administrations in Europe? A benchmarking perspective October 2011.
Evaluating administrative and institutional capacity building
6th EC Framework Programme for Research Scientific Support to Policies: “Integrating and Strengthening the European Research Area” Area (i) Policy-oriented.
CARMEN Policy Observatory and Dialogue Proposal Presentation to the CARMEN Directing Board Meeting San Juan, Puerto Rico 30 June 2003.
A Strategic Framework to Guide Drug Policy Development in Africa
European Clearing-House Mechanism Portal Toolkit Expert Group Meeting
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation.
Information needs for effective drug policy in the programme of the CZ PRES Identifying Europe’s information needs for effective drug policy Lisbon /
The REITOX Experience Lessons learned in developing a network of National Drugs Focal Points and challenges for the future Alan Lodwick, Head of UK National.
European Monitoring Centre for Drugs and Drug Addiction Margareta Nilson ISAJE, Helsinki, 1 September 2006.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS CARDS 2004, Component 4 Early Warning System Tim Pfeiffer-Gerschel National Focal Point.
EFSA MANAGEMENT PLAN 2008 The Management Plan
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,
UNDP Support to UN Cooperation in Moldova Annual Programme Review UNDP Moldova 18 December, 2003.
Working Group on Crime Statistics 9 June 2011 Point 3. Commission Activities ( Doc. CR/WG2011/1)
Annual report 2010: the state of the drugs problem in Europe.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Washington D.C., USA, July 2012www.aids2012.org The HIV/AIDS Civil Society Forum and Think Tank: from policy to action Anna Zakowicz HIV/AIDS Civil.
Marina Kuzman, MD, PhD Croatian National Institute of Public Health National Drug Prevention and Information System in the Republic of Croatia - impact.
DEMOCRACY, CITIES AND DRUGS II Thematic Platforms Presentation Young wanderers and drugs Presentation ANIT is the French federation of health centres and.
EUROPEAN REGIONAL DEVELOPMENT FUND Event – date, place About INTERREG EUROPE INTERREG EUROPE INTERREG IVC Joint Technical Secretariat.
Revision of Problem Drug Use indicator Danica Klempová and Julián Vicente 42nd Reitox HFP meeting, 27 May 2010.
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
ELDD Reflection – past, present and future 29th Meeting of the Scientific Committee, 18 Nov 2008.
Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.
A Strategic Research Agenda for Europe in the field of illicit drugs Priorities for socio-economic and humanities research HDG Brussels - December 10,
1 LIFE+ COUNCIL WORKING GROUP 4 OCTOBER Discussion Points 1. LIFE+ in Context: Environment funding under the Financial Perspectives.
CAST Project funded by the European Commission, Directorate-General Energy & Transport, under the 6th RTD Framework Programme.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,
Gerhard Bühringer, Monika Sassen Institut für Klinische Psychologie und Psychotherapie Institut für Therapieforschung, München EMCDDA work and scientific.
EMCDDA scientific publications Rosemary de Sousa, Head of Communication, 15 June 2009.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
The implementation programme for the 2008 SNA and supporting statistics UNECE special session on National Accounts for economies in transition Geneva,
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
Overview of the three-year work programme (2010–2012) Rosemary de Sousa, Roland Simon, Paul Griffiths 30th ScC meeting, June 2009.
BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.
Directorate E: Agriculture and environment statistics; Statistical cooperation Unit E3: Environment statistics 1 ‘DIMESA 2006’ Preparation Meeting, 13.
Matthias Wentzlaff-Eggebert, BZgA This work is part of the Joint Action on Improving Quality in HIV Prevention (Quality Action), which has received funding.
Monitoring and reporting on the drug phenomenon in Europe EMCDDA mandate and activities Wolfgang Götz, Scientific Committee, Palmela, 14 February 2008.
United Nations Economic Commission for Europe Statistical Division WHAT MAKES AN EFFECTIVE AND EFFICIENT STATISTICAL SYSTEM Lidia Bratanova, Statistical.
First European conference on drug supply indicators, , Brussels – Feed-back Chloé Carpentier, Laurent Laniel, EMCDDA 33 rd meeting of the.
URBACT IMPLEMENTATION NETWORKS. URBACT in a nutshell  European Territorial Cooperation programme (ETC) co- financed by ERDF  All 28 Member States as.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
WHO Estonia country office Marge Reinap Head of WHO Country Office in Estonia.
INCEPTION Beginning Present Outlook
Monitoring drug-related crime in Europe: state of play
Project Coordination Group (PCG) for the implementation of the MSFD
High level seminar on the implementation of the
Marleen De Smedt Geoffrey Thomas Cynthia Tavares
15 June 2009 EMCDDA activities ~ Supply Reduction
Communication and publications
The new three year work programme Visions
Skopje, 21 November 2017, General Population Survey results– launch
Presentation transcript:

Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010

2 Overview Three-year strategy (2010–2012) will be implemented through 3 annual work plans, 2011 WP is the 2’nd Heart of the agency work remains: State of the art review of the drug phenomenon Maintaining an up to date reference point on drugs Providing ongoing support to EU institution and Member states for monitoring and implementing the EU strategy and action plan 2011 WP Highlights Core activities Key indicators Monitoring responses Transversal analysis Supply reduction

focus Ensuring European system fits for the purpose & remaining responsive to developments Further dissemination of best practice Developing information sources in supply reduction Support the evaluation of the EU strategy and action plan Focus on polydrug use, combined analysis, policy-relevance analysis Dissemination and valorising EMCDDA findings 2011 WP Highlights Core activities Key indicators Monitoring responses Transversal analysis Supply reduction

4 State of the art review Preparation of the Annual report package Efficient and methodologically sound data input, management and processing Top level strategic review of data collected and appropriateness of the instruments used Continue development of statistical bulletin Further technical development of FONTE and data warehouse 2011 WP Highlights Core activities Key indicators Monitoring responses Transversal analysis Supply reduction

5 Remain methodologically sound Efficient collection and analysis of the KIs Maintaining and strengthen network Increase quality and comparability Better integration of youth survey (GPS) Final stage of rationalisation of TDI Broadening scope of PDU Update protocol of DRID Improve tools for mortality cohort data collection New data lab workshop (GPS, mortality registries) 2011 WP Highlights Core activities Key indicators Monitoring responses Transversal analysis Supply reduction

6 Support to EC and rationalise data collection Support to the Council recommendation on prevention and reduction of health related harm Investigate and develop models for collecting data on: Opiates substitution treatment GPs Low-threshold agencies Cochrane systematic review on media campaigns Conceptual framework for coherent set of response indicators 2011 WP Highlights Core activities Key indicators Monitoring responses Transversal analysis Supply reduction

7 Cross analysis and CUPs 2011 WP Highlights Core activities Key indicators Monitoring responses Transversal analysis Supply reduction Treatment coverage in subgroups of users Alcohol cannabis connections Polydrug use Drugs and driving CUP treatment: coherent supportive and scientifically sound approach for monitoring treatment in Europe CUP prison: scale up monitoring of prison setting CUP modelling: identify and support policy relevant analyses

8 Development and adoption of indicators 2011 WP Highlights Core activities Key indicators Monitoring responses Transversal analysis Supply reduction Improving understanding of Europe’s specialised police units 3 expert groups (drug markets, drug- related crime, drug supply reduction) Second technical conference on DSSR

9 Combine EWS and emerging trends 2011 WP New drugs Policy Good practice Main outputs Implement efficiently Council Decision (EWS) Assist in assessment of the Council decision Structured internet monitoring Further develop links with forensic/toxicology Trend-spotting- develop integrated approach for monitoring emerging trends Initial implementation of monitoring of misuse of medicinal products Multidisciplinary project on monitoring illicit drugs in waste water

10 Improving Europe’s capacity to monitor and evaluate policies 2011 WP New drugs Policy Good practice Main outputs Review and develop framework for drug policy analysis Study on drug policy advocacy groups Contribute to the evaluation of the EU strategy and action plan And provide appropriate support to the commission in this area Model the impact on unemployment on drug issues

11 Expend BPP and promote cooperation with scientific community 2011 WP New drugs Policy Good practice Main outputs Support EU project on standard and guidelines for interventions harm reduction and social rehabilitation Expend and continue promoting best practice in Europe Promote and facilitate EU research on drug issues Net work with scientific community and relevant organisations

12 Annual report package EU drug strategy Scientific Monograph Insights Manuals Drug policy profiles Drugs in Focus Thematic papers Joint publications Online tools Articles Annual report Statistical bulletin Selected issues (treatment guidelines, cost of treatment, mortality) 2011 WP New drugs Policy Good practice Main outputs

13 Annual report package EU drug strategy Scientific Monograph Insights Manuals Drug policy profiles Drugs in Focus Thematic papers Joint publications Online tools Articles Situation and responses review since WP New drugs Policy Good practice Main outputs EMCDDA public website Best practice portal ELDD Country intervention profiles

14 Annual report package EU drug strategy Scientific Monograph Insights Manuals Drug policy profiles Drugs in Focus Thematic papers Joint publications Online tools Articles New groups of psychoactive substances 2011 WP New drugs Policy Good practice Main outputs European ecstasy market (Europol) Guidance on prevention of infections among IDus (ECDC

15 Annual report package EU drug strategy Scientific Monograph Insights Manuals Drug policy profiles Drugs in Focus Thematic papers Joint publications Online tools Articles 2011 WP New drugs Policy Good practice Main outputs Emerging drug trends case study Drug couriers New methods for cross analysis of prevention trials Drug user perspective in quitting drug use, etc…. Cannabis market and production Heroin-assisted treatment Models of dependency and compulsive behaviour

16 Annual report package EU drug strategy Scientific Monograph Insights Manuals Drug policy profiles Drugs in Focus Thematic papers Joint publications Online tools Articles 2011 WP New drugs Policy Good practice Main outputs DRID protocol Mortality cohort protocol Guidelines for evaluation of national drug strategies Responding to psychoactive substances Minimum quality standard of interventions Drug-related research Khat

17 Annual report package EU drug strategy Scientific Monograph Insights Manuals Drug policy profiles Drugs in Focus Thematic papers Joint publications Online tools Articles 2011 WP New drugs Policy Good practice Main outputs New series of national drug policy profiles

Questions and discussion